Wednesday, May 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Pebblebrook Hotel Trust: CEO Share Sale Coincides with Dividend Declaration

Andreas Sommer by Andreas Sommer
December 17, 2025
in Analysis, Dividends, Insider Trading, Real Estate & REITs
0
Pebblebrook Hotel Stock
0
SHARES
26
VIEWS
Share on FacebookShare on Twitter

Investors in Pebblebrook Hotel Trust are weighing two significant corporate announcements made public on the same day: a substantial stock sale by the company’s chief executive and the declaration of its quarterly dividend.

CEO Transaction and Shareholder Payout Details

Chairman and CEO Jon E. Bortz executed a sale of 50,000 common shares on December 15. The transaction was completed at a weighted average price of $11.263 per share, generating proceeds of approximately $563,150. Following this divestment, Bortz retains direct ownership of more than 1.55 million common shares, in addition to holdings of preferred stock and LTIP units.

Concurrently, the real estate investment trust announced its dividend schedule for the fourth quarter of 2025. A cash distribution of $0.01 per common share is scheduled for payment on January 15, 2026. The company also set regular quarterly dividend rates for its various series of preferred shares.

Should investors sell immediately? Or is it worth buying Pebblebrook Hotel?

Strategic Moves and Market Perspective

Pebblebrook’s recent strategy has focused on portfolio optimization. The firm has divested two hotel properties, located in Chicago and Beverly Hills, in transactions totaling over $116 million. Management has indicated that the proceeds are earmarked primarily for debt reduction and potential share repurchases.

Current analyst sentiment regarding the stock is largely neutral, with a consensus rating hovering around “Hold.” The average price target among market researchers falls within a narrow band, between $12.13 and $12.28 per share. Pebblebrook’s stock closed at $11.61 on December 15, positioning it within this target range.

The market now awaits the company’s 2025 quarterly and annual financial results, which are expected to provide crucial insight into its operational performance and future financial trajectory.

Ad

Pebblebrook Hotel Stock: Buy or Sell?! New Pebblebrook Hotel Analysis from May 13 delivers the answer:

The latest Pebblebrook Hotel figures speak for themselves: Urgent action needed for Pebblebrook Hotel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 13.

Pebblebrook Hotel: Buy or sell? Read more here...

Tags: Pebblebrook Hotel
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Analysis

AbCellera Nears Key Catalyst as Pipeline Candidates Advance

May 4, 2026
Novo Nordisk Stock
Analysis

Novo Nordisk’s China Patent Pause and Washington Pivot Create a Split-Screen Reality

April 26, 2026
Broadcom Stock
Analysis

Broadcom’s AI Chip Empire Tightens as Golden Cross Signals More Upside

April 26, 2026
Next Post
Viking Therapeutics Stock

Viking Therapeutics Stock Consolidates as Market Awaits Next Catalyst

FirstCash Stock

FirstCash Shares: Assessing the Surge Amidst Valuation Concerns

QuantumScape Stock

QuantumScape Executives Capitalize on Share Gains Amid Operational Milestones

Recommended

Murphy Oil Stock

Major Investors Divided on Murphy Oil’s Prospects

9 months ago
Walgreens Stock

Walgreens Implements Drastic Cost-Cutting Measures Under New Ownership

6 months ago
General Electric Stock

GE Aerospace Stock Maintains Impressive Rally Amid Record Performance

7 months ago
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Pharma Giants AstraZeneca and GSK Tap Onco-Innovations’ Causal AI to Sharpen Cancer Trial Predictions

Rocket Lab Transforms from Launch Specialist to Full-Scale Space Supplier as Orders Hit $2.2 Billion

With a 1-for-10 Split Behind It, WisdomTree’s Triple-Leveraged Silver Fund Faces Its Toughest Test Yet

Intel’s Nvidia Deal and $5 Billion Vote of Confidence Overshadowed by Market Headwinds

Quantum eMotion’s Taiwan Test Marks the First Step in a Quantum-Safe Energy Pivot

Aixtron’s Optoelectronics Pivot Fuels a Record Order Book, but the Profit Engine Still Needs Time

Trending

IonQ Stock

IonQ Charts New Territory with Urban Planning and Radar as First 256-Qubit System Ships to Cambridge

by Kennethcix
May 13, 2026
0

IonQ is no longer just a quantum computing research house. The company’s first 256-qubit system has left...

Highland Critical Minerals Stock

Highland Critical Minerals Secures C$400,000 for Summer Fieldwork Amid CIRO Probe and 47% Share Price Rout

May 13, 2026
SoftBank Stock

SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

May 13, 2026
Onco-Innovations Stock

Pharma Giants AstraZeneca and GSK Tap Onco-Innovations’ Causal AI to Sharpen Cancer Trial Predictions

May 13, 2026
Rocket Lab USA Stock

Rocket Lab Transforms from Launch Specialist to Full-Scale Space Supplier as Orders Hit $2.2 Billion

May 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • IonQ Charts New Territory with Urban Planning and Radar as First 256-Qubit System Ships to Cambridge
  • Highland Critical Minerals Secures C$400,000 for Summer Fieldwork Amid CIRO Probe and 47% Share Price Rout
  • SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com